Pradžia › Židininis segmentinis glomerulosklerozė › North Carolina
Židininis segmentinis glomerulosklerozė klinikiniai tyrimai North Carolina
9 tyrimai dėl Židininis segmentinis glomerulosklerozė ieško dalyvių vietose North Carolina.
Miestai North Carolina
Oficialus tyrimo tekstas (anglų kalba)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #16, New Bern
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Duke University Medical Center, Durham
- Carolina Kidney Associates, Greensboro
- Cardinal Clinical Research, LLC - Shelby, Shelby
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- UNC Kidney Center- Site Number : 8400021, Chapel Hill
Renkami dalyviai2 fazė
Amžius nuo 16 iki 75 · Visoms lytims · Atnaujinta 2026-09-23 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- University of North Carolina, Chapel Hill
Renkami dalyviai
Iki 75 metų · Visoms lytims · Atnaujinta 2026-08-28 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- University of North Carolina, Chapel Hill
Renkami dalyviai
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-28 · NCT02235857Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
Renkami dalyviaiStebimasis tyrimas
Iki 80 metų · Visoms lytims · Atnaujinta 2026-06-10 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Renkami dalyviai
Amžius nuo 1 iki 80 · Visoms lytims · Atnaujinta 2026-06-10 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Molecular Physiology Institute, Durham
Renkami dalyviai2 fazė
Amžius nuo 1 iki 17 · Visoms lytims · Atnaujinta 2026-05-12 · NCT05003986A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
Renkami dalyviai3 fazė
Amžius nuo 12 iki 80 · Visoms lytims · Atnaujinta 2026-02-03 · NCT05183646Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.